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1. Introduction 
Calcium affects numerous aspects of cellular 
metabolism [ 1,2] 
[ 1,3] . It has 
been suggested that certain metabolic abnormalities 
of neoplasms are the consequence of massive Cap 
uptake by mitochondria [2] . The factors underlying 
the capacity of tumor mitochondria to accumulate 
large amounts of Ca2’ are presently unclear. This is 
partially due to our lack of understanding of certain 
features of Ca2+ transport by mitochondria from 
normal tissues. 
It is generally accepted that Ca2+ uptake is electro- 
genie and proceeds via a permease which can be 
specifically inhibited by substances uch as ruthenium 
red [4] . There is however lack of agreement regarding 
the mechanism of passive Ca2+ efflux from mitochon- 
dria, e.g., whether Ca2+ release occurs via simple 
reversal of the Ca” permease or involves other path- 
ways [5-l 11. The objectives of the present studies 
were: (a) to determine if Ca2+ efflux is altered in 
tumor mitochondria and thus a factor in their unusual 
facility for accumulating this ion and, (b) to further 
elucidate possible efflux mechanisms for normal and 
tumor mitochondria. 
Rat liver mitochondria and those of Ehrlich ascites 
tumor cells were compared. It was found that Ca2+ 
efflux proceeded via ruthenium red sensitive and 
insensitive pathways. The latter mode of transport 
was much less active in tumor mitochondria. Evidence 
for one possible mechanism of ruthenium red insensi- 
tive Ca2+ efflux, Ca2+ for H’ exchange [ 12,131, was 
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provided by the demonstration that metabolically 
inhibited liver mitochondria can accumulate Car- by 
means of an artificially induced pH gradient. Further- 
more, this activity was not detectable in tumor 
mitochondria. 
2. Experimental 
2.1. Preparation of mitochondria 
A slight modification of the procedure of Schneider 
[ 141 was employed for isolating rat liver mitochondria. 
Mitochondria from Ehrlich ascites tumor cells were 
prepared by the method described by Reynafarje et al. 
[ I.51 
171. sus- 
media 250 sucrose, mM 
(pH 5 Tris-succinate, mM 
30 murexide oligomycin 
pg/ml). temperature maintained 25°C 




were with aerobically 
passive initiated uncoupling 
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The rate of Ca” release from tumor mitochondria 
was only one-third the rate for rat liver (table 1). 
Whereas ruthenium red sensitive efflux was nearly 
identical for the two types of mitochondria, the 
ruthenium red insensitive Ca*+ efflux of liver mito- 
chondria was 18 times more rapid than that of tumor 
mitochondria. The differences in rates of ruthenium 
red insensitive Ca’+ release might reflect either a 
difference in permeability or internal free Ca*+ 
concentration. 
The ionophore A23 187 which catalyzed neutral 
Ca’+ for H’ exchange [ 181 was used to test for dif- 
ferences in the intramitochondrial Ca*’ concentration. 
As shown in table 1 the release rate in the presence of 
A23 187 was actually greater for tumor than liver 
mitochondria. This indicated that tumor mitochondria 
possessed a lower ruthenium red insensitive Ca*+ 
permeability than rat liver rather than simply differing 
in internal free Ca*+. 
The intramitochondrial Ca*+ level was however a 
factor in ruthenium red insensitive Ca*+ translocation. 
If Ca*+ loading of tumor mitochondria exceeded 
600 neq/mg, ruthenium red insensitive efflux rose 
sharply (fig. 1). At 1200 neq/mg. Ca’+ release by this 
pathway was as rapid as for rat liver preloaded with 
300 neq Ca*+/mg. This apparent regulation of 
ruthenium red insensitive Ca*+ permeability could 
reflect damage to the inner mitochondrial membrane 
by high levels of internal Ca*‘. Uncoupling (e.g. 
increased H’ conductance) would be expected if this 
were the case. However basal respiration of liver mito- 
chondria was increased no more than 15% at Ca*+ 
Table 1 
Comparison of Ca” efflux values for rat hver and 
tumor mitochor,dria 
_- ___ 
Parameter Rat Liver Tumor 
Efflux 165 56 
R.R. sensitive efflux 51 50 
R R. insensitive efflux 108 6 
Efflux + A23 187 570 750 
After completion of Ca” uptake (300 neq/mp), Car efflux 
was initiated with I:CCP (4 PM). All flux values are expressed 
in neq Ca’+/min.mg. When included, ruthenium red (4 IJM) 
was added immediately before FCCP. and A23187 (2 pg/ml) 
simultaneously with FCCP. The final mitochondrial protein 
concentration was 4 mg/ml (R.R. = Ruthenium Red) 
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Fig.1. Ruthenium red insensitive Ca’+ efflux as a function of 
the Ca*’ load. The conditions were as described in the legend 
to table 1. 
levels associated with rapid ruthenium red insensitive 
Ca*+ efflux (cf. table 1) and that of tumor mitochon- 
dria was actually somewhat greater under these con- 
ditions yet efflux was much slower. Therefore no 
simple relationship between the degree of uncoupling 
and the rate of ruthenium red insensitive Ca*+ efflux 
was evident (see ref. 19 and section 4). 
3.2. Ruthenium red insensitive Ca*’ transport 
driven b_v a pH gradient 
It was previously postulated that ruthenium red 
insensitive mitochondrial Ca*+ transport might 
proceed by a different mechanism than that of 
ruthenium red sensitive transport, e.g. it could involve 
exchange with protons [12,13]. If such a mechanism 
existed a pH gradient established with dianemycin 
(an ionophore which can catalyze release of endoge- 
nous K’ ions and proton uptake) should drive Ca*+ 
uptake by metabolically inhibited mitochondria. This 
was demonstrated as shown in fig.2. 
Calcium was added to mitochondria in the presence 
of ruthenium red plus uncoupler which prevented 
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Q.2. Calcmm uptake driven by a pU gradient. The medium 
was as described in section 2.2 except succinate was omitted 
and phosphate included as indicated. Prior to addition of 
dianemycin (0.4 &ml). FCCP (2 GM), ruthenium red (4 MM) 
and CaCl, were added sequentially. In A, the protein concen- 
tration was 4.6 mg/ml. Cal+ added 20 neq/mg and, when 
included, A231 87.0.4 fig/ml. In B, 3.7 mg protein/ml, 
IO0 neq Ca”/mg and A23187,2 #g/m& was employed. 
energy-linked uptake. Upon addition of dianemycin, 
Ca” was accumulated by rat liver (fig.2A) but not 
tumor mitoch~rld~a (fig.2B) although they released 
comparable accounts of K+ (measured with a K” 
sensitive electrode). The ionophore A23 187 enhanced 
pH gradient driven Ca*’ flux in rat liver mitochondria 
and was required for Ca”’ uptake by tumor mitochon- 
dria. Thus Ca” accumulation could occur in tumor 
mitochondria given the appropriate permeability. 
Phosphate inhibited these Ca” movements which 
provided further evidence that they were driven by 
the pH gradient set up by dianemycin. This inhibition 
most likely resulted from ~ol~lpetition by the 
phosphate~OH_ transport system [20] for the 
imposed pH gradient. 
4. Discussion 
It has been reported that there is no substantial 
difference between the kinetics for Ca* uptake by 
tumor and rat liver mitochondria [Z] . Yet under 
most conditions the maximum net uptake of Ca” by 
tumor mitochondria is much greater [15,21,22]. In 
the present studies a significant difference in the rate 
of release of accumulated Ca” from normal and 
tumor mitocho~dria was demonstrated. Since Ca” 
uptake rates for normal and tumor mitochondria are 
comparabIe, the comparatively slow Ca” efflux from 
tumor mito~llondria appears to be a significant factor 
in their greater uptake capacity although it need not 
be solely responsible. 
The most significant difference in Ca” efflux for 
the two types of lnito~hondria was the relative 
inactivity of the ruthenium red insensitive pathway 
in tumor mitochondria. In contrast, ruthenium red 
sensitive Ca2+ transport either in the case of influx 
[2] or passive efflux (table 1) appears to be unaltered 
in tumor mitochondria. 
The mec~lanism of rutheni~lm red insensitive Ca” 
efflux is not known. Evidence presented here indicates 
a pH gradient can drive ruthenium red insensitive 
Ca*” translocation. Uncoupling agent stimulates this 
transport of Ca2+ (unpublished experiments) which 
suggests it is electrogenic, for example, a Ca”/H’ 
antiport [S] , Uncoupling agent is also necessary for 
rapid ruthenium red insensitive CaZ+ efflux (see also 
refs. 8,9) which suggests it too is electrogenic. This is 
reminiscent of electrogenic Ca*‘/Na+ exchange of 
heart mitochondria [lO,l 11 although this activity 
appears to be negligible in rat liver m~tochondr~a 
[IO] . Other explanations of ruthenium red insensitive 
Ca2+ efflux are not excluded by results presented 
here, for example,electrophoretic Ca2+ effIux indirect- 
ly coupled to the counterflow of protons through a 
I-I’ ‘leak’ [X9]. However the recent report that 
oxidation of pyridine nucleotides acceierates 
ruthenium red insensitive release of mitochondriaf 
Ca*+ [23] with no apparent effect upon membrane 
integrity or coupling does not comply with a simple 
proton “leak’ mechanism ] 191. These studies are 
interpreted in terms of separate pathways for Ca2’ 
influx and efflux [23] such as inferred from the 
results presented here. Further studies of regulatory 
factors such as pyridine nucfeotides 1231 in liver and 
tumor mitochondria are necessary to clarify the 
mechanism of Ca2+ efflux for which the pH driven 
Ca** uptake system may provide one useful approach. 
Different modes of mitochondrial Ca* influx and 
eff’lux may be important in cellular Cazi homesostasis 
particularly since they may be regulated separately 
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